Imaging angiogenesis, inflammation, and metastasis in the tumor microenvironment with magnetic resonance imaging

Advances in Experimental Medicine and Biology

Volumn 772, Issue , 2014, Pages 263-283

  Serres, Sébastien ^a,b   O'Brien, Emma R ^a   Sibson, Nicola R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Cancer; Inflammation; Magnetic resonance imaging; Metastasis; Tumour microenvironment; Vasculature

Indexed keywords

CONTRAST MEDIUM;

ANGIOGENESIS; APOPTOSIS; BLOOD VESSEL PERMEABILITY; CELL COMPONENT; CELL MOTION; CELL TRACKING; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; METABOLIC REGULATION; MOLECULAR IMAGING; MOLECULAR MECHANICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPIN LABELING; TUMOR BLOOD FLOW; TUMOR INVASION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANIMALS; BLOOD VOLUME DETERMINATION; BRAIN NEOPLASMS; CONTRAST MEDIA; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MOLECULAR PROBES; NEOVASCULARIZATION, PATHOLOGIC; REGIONAL BLOOD FLOW; SPIN LABELS; TUMOR MICROENVIRONMENT;

EID: 84934438418     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-5915-6_12     Document Type: Conference Paper

References (122)

1. Ahrens ET, Flores R, Xu H, Morel PA (2005) In vivo imaging platform for tracking immunothera-peutic cells. Nat Biotechnol 23:983-987
2. Alsop DC, Detre JA (1996) Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 16:1236-1249
3. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA (2003) Characterization of biophysical and metabolic properties of cells labeled with superparamag-netic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 229:838-846
4. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41-51
5. Aronen HJ, Pardo FS, Kennedy DN, Belliveau JW, Packard SD, Hsu DW, Hochberg FH, Fischman AJ, Rosen BR (2000) High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 6:2189-2200
6. Bataveljic D, Stamenkovic S, Bacic G, Andjus PR (2011) Imaging cellular markers of neuroin-flammation in the brain of the rat model of amyotrophic lateral sclerosis. Acta Physiol Hung 98:27-31
7. Bauerle T, Komljenovic D, Merz M, Berger MR, Goodman SL, Semmler W (2011) Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study. Int J Cancer 128:2453-2462
8. Bauerle T, Komljenovic D, Semmler W (2012) Monitoring molecular, functional and morphologic aspects of bone metastases using non-invasive imaging. Curr Pharm Biotechnol 13:584-594
9. Bell LK, Ainsworth NL, Lee SH, Griffiths JR (2011) MRI & MRS assessment of the role of the tumour microenvironment in response to therapy. NMR Biomed 24:612-635
10. Bhorade R, Weissleder R, Nakakoshi T, Moore A, Tung CH (2000) Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjug Chem 11:301-305
11. Boulland JL, Leung DS, Thuen M, Vik-Mo E, Joel M, Perreault MC, Langmoen IA, Haraldseth O, Glover JC (2012) Evaluation of intracellular labeling with micron-sized particles of iron oxide (MPIOs) as a general tool for in vitro and in vivo tracking of human stem and progenitor cells. Cell Transplant 21:1743-1759
12. Brindle K (2008) New approaches for imaging tumour responses to treatment. Nat Rev Cancer 8:94-107
13. Brown JM, WILSON WR (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4:437-447
14. Budde MD, Gold E, Jordan EK, Frank JA (2012) Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI. Clin Exp Metastasis 29:51-62
15. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR (1998) A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med 40:383-396
16. Carbonell WS, Ansorge O, Sibson N, Muschel R (2009) The vascular basement membrane as "soil" in brain metastasis. PLoS One 4:e5857
17. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438:932-936
18. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257
19. Cerdan S, Lotscher HR, Kunnecke B, Seelig J (1989) Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors. Magn Reson Med 12:151-163
20. Chaumeil MM, Gini B, Yang H, Iwanami A, Sukumar S, Ozawa T, Pieper RO, Mischel PS, James CD, Berger MS, Ronen SM (2012) Longitudinal evaluation of MPIO-labeled stem cell biodis-tribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla. Neuro Oncol 14:1050-1061
21. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30:1073-1081
22. Combes S, Jacob S, Combes N, Karam N, Chaumeil A, Guy-Moyat B, Treguer F, Deplagne A, Boveda S, Marijon E, Albenque JP (2013) Predicting favourable outcomes in the setting of radiofrequency catheter ablation of long-standing persistent atrial fibrillation: a pilot study assessing the value of left atrial appendage peak flow velocity. Arch Cardiovasc Dis 106:36-43
23. de Vries IJ, Lesterhuis WJ, Barentsz JO, Verdijk P, van Krieken JH, Boerman OC, Oyen WJ, Bonenkamp JJ, Boezeman JB, Adema GJ, Bulte JW, Scheenen TW, Punt CJ, Heerschap A, Figdor CG (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 23:1407-1413
24. Deddens LH, van Tilborg GA, van Der Toorn A, van Der Marel K, Paulis LE, van Bloois L, Storm G, Strijkers GJ, Mulder WJ, de Vries HE, Dijkhuizen RM (2013) MRI of ICAM-1 upregulation after stroke: the importance of choosing the appropriate target-specific particulate contrast agent. Mol Imaging Biol 15(4):411-422
25. Denardo DG, Andreu P, Coussens LM (2010) Interactions between lymphocytes and myeloid cells regulate pro-versus anti-tumor immunity. Cancer Metastasis Rev 29:309-316
26. Detre JA, Leigh JS, Williams DS, Koretsky AP (1992) Perfusion imaging. Magn Reson Med 23:37-45
27. Domingo G, Perez CA, Velez M, Cudris J, Raez LE, Santos ES (2010) EGF receptor in lung cancer: a successful story of targeted therapy. Expert Rev Anticancer Ther 10:1577-1587
28. Dvorak HF, Galli SJ, Dvorak AM (1986) Cellular and vascular manifestations of cell-mediated immunity. Hum Pathol 17:122-137
29. Ferjancic S, Gil-Bernabe AM, Hill SA, Allen PD, Richardson P, Sparey T, Savory E, Mcguffog J, Muschel RJ (2013) VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice. Blood 121(16):3289-3297
30. Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438:967-974
31. Fleige G, Nolte C, Synowitz M, Seeberger F, Kettenmann H, Zimmer C (2001) Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 3:489-499
32. Fokas E, Mckenna WG, Muschel RJ (2012) The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies. Cancer Metastasis Rev 31:823-842
33. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182-1186
34. Gao Z, Zhang L, Hu J, Sun Y (2013) Mesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticles. Nanomedicine 9:174-184
35. Geelen T, Yeo S Y, Paulis LE, Starmans LW, Nicolay K, Strijkers GJ (2012) Internalization of paramagnetic phosphatidylserine-containing liposomes by macrophages. J Nanobiotechnology 10:37
36. Goldschmidt P, Degorge S, Benallaoua D, Batellier L, Di Cave D, Chaumeil C (2012) Rapid detection and simultaneous molecular profile characterization of Acanthamoeba infections. Diagn Microbiol Infect Dis 74:137-141
37. Hahn PF, Weissleder R, Stark DD, Saini S, Elizondo G, Ferrucci JT (1988) MR imaging of focal splenic tumors. AJR Am J Roentgenol 150:823-827
38. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646-674
39. Harisinghani MG, Weissleder R (2004) Sensitive, noninvasive detection of lymph node metasta-ses. PLoS Med 1:e66
40. Harisinghani MG, Barentsz J, Hahn PF, Deserno WM, Tabatabaei S, van de Kaa CH, de la Rosette J, Weissleder R (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491-2499
41. Heijmen L, Verstappen MC, Ter Voert EE, Punt CJ, Oyen WJ, de Geus-Oei LF, Hermans JJ, Heerschap A, van Laarhoven HW (2012) Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use? Crit Rev Oncol Hematol 83:194-207
42. Heyn C, Ronald JA, Mackenzie LT, Macdonald IC, Chambers AF, Rutt BK, Foster PJ (2006a) In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn Reson Med 55:23-29
43. Heyn C, Ronald JA, Ramadan SS, Snir JA, Barry AM, Kmackenzie LT, Mikulis DJ, Palmieri D, Bronder JL, Steeg PS, Yoneda T, Macdonald IC, Chambers AF, Rutt BK, Foster PJ (2006b) In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn Reson Med 56:1001-1010
44. Hoefnagels FW, Lagerwaard FJ, Sanchez E, Haasbeek CJ, Knol DL, Slotman BJ, Vandertop WP (2009) Radiological progression of cerebral metastases after radiosurgery: assessment of per-fusion MRI for differentiating between necrosis and recurrence. J Neurol 256:878-887
45. Hoyte LC, Brooks KJ, Nagel S, Akhtar A, Chen R, Mardiguian S, Mcateer MA, Anthony DC, Choudhury RP, Buchan AM, Sibson NR (2010) Molecular magnetic resonance imaging of acute vascular cell adhesion molecule-1 expression in a mouse model of cerebral ischemia. J Cereb Blood Flow Metab 30:1178-1187
46. Ihnen M, Kilic E, Kohler N, Loning T, Witzel I, Hagel C, Holler S, Kersten JF, Muller V, Janicke F, Milde-Langosch K (2011) Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin. J Clin Pathol 64:146-152
47. Jackson A, O'Connor J, Thompson G, Mills S (2008) Magnetic resonance perfusion imaging in neuro-oncology. Cancer Imaging 8:186-199
48. Joyal CC, Pennanen C, Tiihonen E, Laakso MP, Tiihonen J, Aronen HJ (2004) MRI volumetry of the vermis and the cerebellar hemispheres in men with schizophrenia. Psychiatry Res 131:115-124
49. Jung CW, Jacobs P (1995) Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 13:661-674
50. Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, JIRIK R, Miletic H, Wang J, Stieber D, Stuhr L, Moen I, Rygh CB, Bjerkvig R, Niclou SP (2011) Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glio-blastoma. Proc Natl Acad Sci USA 108:3749-3754
51. Kircher MF, Gambhir SS, Grimm J (2011) Noninvasive cell-tracking methods. Nat Rev Clin Oncol 8:677-688
52. Kleijn A, Chen JW, Buhrman JS, Wojtkiewicz GR, Iwamoto Y, Lamfers ML, Stemmer-Rachamimov AO, Rabkin SD, Weissleder R, Martuza RL, Fulci G (2011) Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imaging. Clin Cancer Res 17:4484-4493
53. Klemke M, Weschenfelder T, Konstandin MH, Samstag Y (2007) High affinity interaction of inte-grin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers. J Cell Physiol 212:368-374
54. Laubli H, Borsig L (2010) Selectins promote tumor metastasis. Semin Cancer Biol 20: 169-177
55. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715-721
56. Law M, Teicher N, Zagzag D, Knopp EA (2003a) Dynamic contrast enhanced perfusion MRI in mycosis fungoides. J Magn Reson Imaging 18:364-367
57. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D (2003b) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989-1998
58. Leenders W, Kusters B, Pikkemaat J, Wesseling P, Ruiter D, Heerschap A, Barentsz J, de Waal RM (2003) Vascular endothelial growth factor-A determines detectability of experimental melanoma brain metastasis in GD-DTPA-enhanced MRI. Int J Cancer 105:437-443
59. Liu Y, Karonen JO, Vanninen RL, Nuutinen J, Koskela A, Soimakallio S, Aronen HJ (2004) Acute ischemic stroke: predictive value of 2D phase-contrast MR angiography-serial study with combined diffusion and perfusion MR imaging. Radiology 231:517-527
60. Mcateer MA, Sibson NR, von Zur Muhlen C, Schneider JE, Lowe AS, Warrick N, Channon KM, Anthony DC, Choudhury RP (2007) In vivo magnetic resonance imaging of acute brain inflam-mation using microparticles of iron oxide. Nat Med 13:1253-1258
61. Milanezi F, Carvalho S, Schmitt FC (2008) EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy. Expert Rev Mol Diagn 8:417-434
62. Miller JC, Pien HH, Sahani D, Sorensen AG, Thrall JH (2005) Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst 97:172-187
63. Moffat BA, Chenevert TL, Lawrence TS, Meyer CR, Johnson TD, Dong Q, Tsien C, Mukherji S, Quint DJ, Gebarski SS, Robertson PL, Junck LR, Rehemtulla A, Ross BD (2005) Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 102:5524-5529
64. Moore A, Weissleder R, Bogdanov A Jr (1997) Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging 7:1140-1145
65. Neuwelt EA, Varallyay P, Bago AG, Muldoon LL, Nesbit G, Nixon R (2004) Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol Appl Neurobiol 30:456-471
66. Nguyen DX, Bos PD, Massague J (2009) Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 9:274-284
67. O'connor JP, Jackson A, Parker GJ, Jayson GC (2007) DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 96:189-195
68. Oude Engberink RD, Blezer EL, Dijkstra CD, van Der Pol SM, van Der Toorn A, de Vries HE (2010) Dynamics and fate of USPIO in the central nervous system in experimental autoimmune encephalomyelitis. NMR Biomed 23:1087-1096
69. Partlow KC, Chen J, Brant JA, Neubauer AM, Meyerrose TE, Creer MH, Nolta JA, Caruthers SD, Lanza GM, Wickline SA (2007) 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB J 21:1647-1654
70. Paulis LE, Jacobs I, van Den Akker NM, Geelen T, Molin DG, Starmans LW, Nicolay K, Strijkers GJ (2012) Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent. J Nanobiotechnology 10:25
71. Perini R, Choe R, Yodh AG, Sehgal C, Divgi CR, Rosen MA (2008) Non-invasive assessment of tumor neovasculature: techniques and clinical applications. Cancer Metastasis Rev 27:615-630
72. Perkio J, Soinne L, Ostergaard L, Helenius J, Kangasmaki A, Martinkauppi S, Salonen O, Savolainen S, Kaste M, Tatlisumak T, Aronen HJ (2005) Abnormal intravoxel cerebral blood flow heterogeneity in human ischemic stroke determined by dynamic susceptibility contrast magnetic resonance imaging. Stroke 36:44-49
73. Pirko I, Ciric B, Johnson AJ, Gamez J, Rodriguez M, Macura S (2003) Magnetic resonance imaging of immune cells in inflammation of central nervous system. Croat Med J 44:463-468
74. Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848
75. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141:39-51
76. Rausch M, Baumann D, Neubacher U, Rudin M (2002) In-vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed 15:278-283
77. Roberts HC, Roberts TP, Ley S, Dillon WP, Brasch RC (2002) Quantitative estimation of micro-vascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. Acad Radiol 9(Suppl 1):S151-S155
78. Roland CL, Harken AH, Sarr MG, Barnett CC Jr (2007) ICAM-1 expression determines malignant potential of cancer. Surgery 141:705-707
79. Saif MW (2010) Colorectal cancer in review: the role of the EGFR pathway. Expert Opin Investig Drugs 19:357-369
80. Saudek F, Jirak D, Girman P, Herynek V, Dezortova M, Kriz J, Peregrin J, Berkova Z, Zacharovova K, Hajek M (2010) Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation 90:1602-1606
81. Sauter G, Maeda T, Waldman FM, Davis RL, Feuerstein BG (1996) Patterns of epidermal growth factor receptor amplification in malignant gliomas. Am J Pathol 148:1047-1053
82. Schafer R, Bantleon R, Kehlbach R, Siegel G, Wiskirchen J, Wolburg H, Kluba T, Eibofner F, Northoff H, Claussen CD, Schlemmer HP (2010) Functional investigations on human mesen-chymal stem cells exposed to magnetic fields and labeled with clinically approved iron nanoparticles. BMC Cell Biol 11:22
83. Schmieder AH, Winter PM, Caruthers SD, Harris TD, Williams TA, Allen JS, Lacy EK, Zhang H, Scott MJ, Hu G, Robertson JD, Wickline SA, Lanza GM (2005) Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles. Magn Reson Med 53:621-627
84. Schwechheimer K, Huang S, Cavenee WK (1995) EGFR gene amplification-rearrangement in human glioblastomas. Int J Cancer 62:145-148
85. Serres S, Anthony DC, Jiang Y, Broom KA, Campbell SJ, Tyler DJ, van Kasteren SI, Davis BG, Sibson NR (2009) Systemic inflammatory response reactivates immune-mediated lesions in rat brain. J Neurosci 29:4820-4828
86. Serres S, Mardiguian S, Campbell SJ, Mcateer MA, Akhtar A, Krapitchev A, Choudhury RP, Anthony DC, Sibson NR (2011) VCAM-1-targeted magnetic resonance imaging reveals sub-clinical disease in a mouse model of multiple sclerosis. FASEB J 25:4415-4422
87. Serres S, Soto MS, Hamilton A, Mcateer MA, Carbonell WS, Robson MD, Ansorge O, Khrapitchev A, Bristow C, Balathasan L, Weissensteiner T, Anthony DC, Choudhury RP, Muschel RJ, Sibson NR (2012) Molecular MRI enables early and sensitive detection of brain metastases. Proc Natl Acad Sci USA 109:6674-6679
88. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP (2004) MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 101:10901-10906
89. Shapiro EM, Skrtic S, Koretsky AP (2005) Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn Reson Med 53:329-338
90. Shazeeb MS, Sotak CH, Deleo M 3rd, Bogdanov A Jr (2011) Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma. Cancer Res 71:2230-2239
91. Shen JF, Saunders JK (1993) Double inversion recovery improves water suppression in vivo. Magn Reson Med 29:540-542
92. Shen T, Weissleder R, Papisov M, Bogdanov A Jr, Brady TJ (1993) Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn Reson Med 29:599-604
93. Sipe JC, Filippi M, Martino G, Furlan R, Rocca MA, Rovaris M, Bergami A, Zyroff J, Scotti G, Comi G (1999) Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn Reson Imaging 17:1521-1523
94. Sitohy B, Nagy JA, Dvorak HF (2012) Anti-VEGF/VEGFR therapy for cancer: reassessing the target. Cancer Res 72:1909-1914
95. Song HT, Jordan EK, Lewis BK, Gold E, Liu W, Frank JA (2011) Quantitative T2* imaging of metastatic human breast cancer to brain in the nude rat at 3 T. NMR Biomed 24:325-334
96. Sundstrom T, Daphu I, Wendelbo I, Hodneland E, Lundervold A, Immervoll H, Skaftnesmo KO, Babic M, Jendelova P, Sykova E, Lund-Johansen M, Bjerkvig R, Thorsen F (2013) Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model. Cancer Res 73(8):2445-2456
97. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
98. Unger EC (2003) How can superparamagnetic iron oxides be used to monitor disease and treatment? Radiology 229:615-616
99. Valable S, Barbier EL, Bernaudin M, Roussel S, Segebarth C, Petit E, Remy C (2007) In vivo MRI tracking of exogenous monocytes/macrophages targeting brain tumors in a rat model of gli-oma. Neuroimage 37(Suppl 1):S47-S58
100. van Kasteren SI, Campbell SJ, Serres S, Anthony DC, Sibson NR, Davis BG (2009) Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease. Proc Natl Acad Sci USA 106:18-23
101. von Zur Muhlen C, Sibson NR, Peter K, Campbell SJ, Wilainam P, Grau GE, Bode C, Choudhury RP, Anthony DC (2008) A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI. J Clin Invest 118:1198-1207
102. Wang J, Alsop DC, Li L, Listerud J, Gonzalez-AT JB, Schnall MD, Detre JA (2002) Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla. Magn Reson Med 48:242-254
103. Wang J, Rao H, Wetmore GS, Furlan PM, Korczykowski M, Dinges DF, Detre JA (2005) Perfusion functional MRI reveals cerebral blood flow pattern under psychological stress. Proc Natl Acad Sci USA 102:17804-17809
104. Warmuth C, Gunther M, Zimmer C (2003) Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology 228:523-532
105. Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452:580-589
106. Weissleder R, Hahn PF, Stark DD, Rummeny E, Saini S, Wittenberg J, Ferrucci JT (1987a) MR imaging of splenic metastases: ferrite-enhanced detection in rats. AJR Am J Roentgenol 149:723-726
107. Weissleder R, Stark DD, Compton CC, Wittenberg J, Ferrucci JT (1987b) Ferrite-enhanced MR imaging of hepatic lymphoma: an experimental study in rats. AJR Am J Roentgenol 149:1161-1165
108. Weissleder R, Hahn PF, Stark DD, Elizondo G, Saini S, Todd LE, Wittenberg J, Ferrucci JT (1988a) Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging. Radiology 169:399-403
109. Weissleder R, Stark DD, Elizondo G, Hahn PF, Compton C, Saini S, Wittenberg J, Ferrucci JT (1988b) MRI of hepatic lymphoma. Magn Reson Imaging 6:675-681
110. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ (1990) Ultrasmall super-paramagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175:494-498
111. Weissleder R, Bogdanov A, Papisov M (1992) Drug targeting in magnetic resonance imaging. Magn Reson Q 8:55-63
112. Weissleder R, Cheng HC, Bogdanova A, Bogdanov A Jr (1997) Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 7:258-263
113. Wiiger MT, Gehrken HB, Fodstad O, Maelandsmo GM, Andersson Y (2010) A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth. Cancer Immunol Immunother 59:1665-1674
114. Williams DS, Detre JA, Leigh JS, Koretsky AP (1992) Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 89:212-216
115. Wolf RL, Wang J, Wang S, Melhem ER, O'Rourke DM, Judy KD, Detre JA (2005) Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla. J Magn Reson Imaging 22:475-482
116. Wong EC, Buxton RB, Frank LR (1998) A theoretical and experimental comparison of continuous and pulsed arterial spin labeling techniques for quantitative perfusion imaging. Magn Reson Med 40:348-355
117. Wong EC, Cronin M, Wu WC, Inglis B, Frank LR, Liu TT (2006) Velocity-selective arterial spin labeling. Magn Reson Med 55:1334-1341
118. Yankeelov TE, Lepage M, Chakravarthy A, Broome EE, Niermann KJ, Kelley MC, Meszoely I, Mayer IA, Herman CR, Mcmanus K, Price RR, Gore JC (2007) Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 25:1-13
119. Zhang C, Jugold M, Woenne EC, Lammers T, Morgenstern B, Mueller MM, Zentgraf H, Bock M, Eisenhut M, Semmler W, Kiessling F (2007) Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res 67:1555-1562
120. Zhang F, Huang X, Zhu L, Guo N, Niu G, Swierczewska M, Lee S, Xu H, Wang AY, Mohamedali KA, Rosenblum MG, Lu G, Chen X (2012) Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles. Biomaterials 33:5414-5422
121. Zimmer C, Weissleder R, O'Connor D, Lapointe L, Brady TJ, Enochs WS (1995a) Cerebral iron oxide distribution: in vivo mapping with MR imaging. Radiology 196:521-527
122. Zimmer C, Weissleder R, Poss K, Bogdanova A, Wright SC Jr, Enochs WS (1995b) MR imaging of phagocytosis in experimental gliomas. Radiology 197:533-538